Showing 11,441 - 11,460 results of 24,223 for search '(( 50 ((mean decrease) OR (nn decrease)) ) OR ( 100 ((a decrease) OR (we decrease)) ))', query time: 0.67s Refine Results
  1. 11441

    DataSheet1_Global burden of chronic kidney disease in adolescents and young adults, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.docx by Ping Sun (59933)

    Published 2024
    “…However, the global age-specific death rate significantly decreased from 2.96 (2.76, 3.15) to 2.86 (2.61, 3.11), and the age-specific DALY rate remained stable. …”
  2. 11442

    Comprehensive Evaluation and Implementation of Improvement Actions in Butcher Shops by Gerardo A. Leotta (3115335)

    Published 2016
    “…A comprehensive evaluation was made and risk was quantified on a 1–100 scale as high-risk (1–40), moderate-risk (41–70) or low-risk (71–100). …”
  3. 11443

    DataSheet_1_Leveraging intelligent optimization for automated, cardiac-sparing accelerated partial breast treatment planning.xlsx by Joel A. Pogue (14597114)

    Published 2023
    “…Here we investigate the feasibility of automatically generating high quality APBI plans in the Ethos adaptive workspace with a specific emphasis on sparing the heart.…”
  4. 11444

    Table_1_Leveraging intelligent optimization for automated, cardiac-sparing accelerated partial breast treatment planning.docx by Joel A. Pogue (14597114)

    Published 2023
    “…Here we investigate the feasibility of automatically generating high quality APBI plans in the Ethos adaptive workspace with a specific emphasis on sparing the heart.…”
  5. 11445

    Table_1_Effectiveness of sofosbuvir-based treatments for patients with hepatitis C virus genotype 6 infection: a real-world study from East China.DOC by Fan-Rong Jiang (20325720)

    Published 2024
    “…In PP population, the end of treatment virological response rate was 99.48% (190/191), the SVR12 rate was 99.31% (143/144), and the SVR24 rate was 100.00% (75/75). Only one patient with genotype 6a experienced a relapse 12 weeks after the completion of treatment, but her HCV RNA was undetectable both at the end of treatment and 24 weeks after the end of treatment. …”
  6. 11446

    Table 1_Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial.docx by Xinhui Yang (12051251)

    Published 2025
    “…Intragroup analysis indicated a significant decrease in TMAO levels at 6 months compared with baseline (adjusted p<0.05). …”
  7. 11447

    Table 3_Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial.docx by Xinhui Yang (12051251)

    Published 2025
    “…Intragroup analysis indicated a significant decrease in TMAO levels at 6 months compared with baseline (adjusted p<0.05). …”
  8. 11448

    Table 2_Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial.docx by Xinhui Yang (12051251)

    Published 2025
    “…Intragroup analysis indicated a significant decrease in TMAO levels at 6 months compared with baseline (adjusted p<0.05). …”
  9. 11449

    Data Sheet 1_Global, regional, and national trends and burden of multiple sclerosis in adolescents and young adults: a data analysis from 1990 to 2021 and projections to 2040.zip by Peixi Zhao (620068)

    Published 2025
    “…</p>Methods<p>Using data from the GBD 2021 data, we conducted a secondary analysis. We assessed the prevalence, mortality, and disability-adjusted life years (DALYs) of MS across 204 countries/territories from 1990 to 2021, calculating age-standardized rates.…”
  10. 11450

    Data Sheet 2_Global, regional, and national trends and burden of multiple sclerosis in adolescents and young adults: a data analysis from 1990 to 2021 and projections to 2040.docx by Peixi Zhao (620068)

    Published 2025
    “…</p>Methods<p>Using data from the GBD 2021 data, we conducted a secondary analysis. We assessed the prevalence, mortality, and disability-adjusted life years (DALYs) of MS across 204 countries/territories from 1990 to 2021, calculating age-standardized rates.…”
  11. 11451
  12. 11452

    Supplementary Material for: A Case of Granulocyte-Colony-Stimulating Factor-Producing Non-Small Cell Lung Cancer under Steroid Treatment and with Poor Performance Status that respo... by Egusa H. (19645753)

    Published 2024
    “…She had fever and her PS was 3, and her CRP was 6.47 mg/dL due to inflammation by a G-CSF-producing tumor. Thus, we initiated the administration of dexamethasone (3.3 mg/day). …”
  13. 11453

    Table_1_Association of Yogurt and Dietary Supplements Containing Probiotic Consumption With All-Cause and Cause-Specific Mortality in US Adults: A Population-Based Cohort Study.XLS by Ping Lin (146330)

    Published 2022
    “…</p>Methods<p>We conducted an observational cohort study comprised of a nationally representative sample of adults who were enrolled in the National Health and Nutrition Examination Survey (NHANES) between 1999 and 2014. …”
  14. 11454

    Data_Sheet_1_Platelet Measurements and Type 2 Diabetes: Investigations in Two Population-Based Cohorts.docx by Benjamin A. T. Rodriguez (9107027)

    Published 2020
    “…<p>Type 2 diabetes is a major risk factor for cardiovascular disease. …”
  15. 11455

    Risk of Urogenital Infections in People with Type 2 Diabetes Initiating SGLT2i versus GLP-1RA in Routine Clinical Care: A Danish Cohort Study by Christine Ljungberg (20880865)

    Published 2025
    “…</p><p><br></p><p dir="ltr">Results </p><p dir="ltr">This study included 52,414 SGLT2i initiators and 27,023 GLP-1RA initiators with a median follow-up of 2.9 to 3.9 years. The estimated risks of UTI within the first year were nearly identical: 10.0% in SGLT2is, 10.2% in GLP-1RAs in intention-to-treat analyses corresponding to a risk ratio of 0.98 (95% CI 0.94, 1.03). …”
  16. 11456

    Deletion of <i>Rps6</i> in adult liver induces hepatocyte apoptosis and triggers regeneration. by Sarah A. Comerford (3854917)

    Published 2023
    “…Scale bars: a), c) and d), 100μ; b) and e), 50μ. (F) Photomicrographs of IHC for PCNA, phospho-RPS6<sup>(Ser235/6)</sup> and pan-cytokeratin (CK) on livers of ΔS6<sup>dox</sup> mice provided with dox for 54 days showing that regenerating nodules contain PCNA- and phospho-RPS6<sup>(Ser235/6)</sup>-positive immature hepatocytes while pan-CK-positive cells comprise the dr. …”
  17. 11457

    FLIM imaging of live mouse intestinal organoids stained with HXT (1.5 μM, 4 h) and BrdU. by Irina A. Okkelman (3544946)

    Published 2016
    “…(<b>e</b>) FLIM image of an individual crypt from organoid incubated with BrdU (100 μM, 4 h) shows fewer nuclei with decreased τ<sub>m</sub>. …”
  18. 11458
  19. 11459

    Outline of results for spine maturation. by C. A. Miermans (3716515)

    Published 2017
    “…For these plots we used <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0170113#pone.0170113.e029" target="_blank">Eq 2</a> with . …”
  20. 11460

    DataSheet_1_Patients With Chronic Hepatitis C Virus Infection Are at an Increased Risk of Colorectal Cancer: A Nationwide Population-Based Case-Control Study in Taiwan.doc by Fu-Hsiung Su (301644)

    Published 2021
    “…The CRC risk was slightly greater for women than for men. The risk decreased with age, with the aOR decreased from 2.26 (95% CI = 1.32–3.87, p = 0.003) in patients under 45 years old to 1.31 (95% CI = 1.10–1.55, p = 0.03) in patients aged 50–59, and 1.10 (95% CI = 1.00–1.22, p = 0.061) in patients aged over 70.…”